Fig. 6From: Targeted delivery and ROS-responsive release of Resolvin D1 by platelet chimeric liposome ameliorates myocardial ischemia–reperfusion injuryCardiac protection efficiency of PLP-RvD1. A Cardiac function was assessed by echocardiography at 4 weeks after treatment (n = 6 per group). B Masson staining of MI/R heart paraffin sections at 4 weeks after various treatments. Scalar bar, 1 mm. C LVAW thickness and D fibrosis remodeling in (B) was quantified by using ImageJ software (n = 6 per group). Results are presented as mean ± SD. NSP > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001Back to article page